The gut microbiome—comprising trillions of microorganisms including bacteria, fungi, viruses, and archaea—plays a crucial role in overall health. These microbes reside on the skin, in the mouth, and most abundantly in the intestines, forming a dynamic ecosystem that influences nearly every aspect of wellbeing.
A balanced microbiome aids digestion, produces essential nutrients, strengthens the immune system, and helps regulate metabolism. However, when harmful species overgrow or beneficial ones decline—a condition known as dysbiosis—this delicate balance is disrupted, potentially leading to wide-ranging health problems.
Microorganisms in the gut fall broadly into two categories:
Although there are certain symptoms, such as indigestion, mood swings, and skin disorders, which can indicate a microorganism imbalance, these symptoms can also have other causes. As such, it is important to understand the relationship between symptoms and the gut microbiome through the use of screening.
There is a form of screening for the harmful and health-promoting microorganisms in the body using stool analysis performed in a laboratory setting. This screening can help medical staff understand the following aspects of a patient’s health:
Should the density, variety, and number of health-promoting microorganisms in the body be imbalanced, it could result in a greater risk of disease when compared to a balanced situation. This form of screening, therefore, enables medical staff to assess a patient’s risk of disease, as well as diagnoses any disorders that could be resulting from a gut microbiome imbalance, including irritable bowel syndrome, obesity, diabetes, migraines, anxiety, and depression.
Redressing gut microbiome imbalances with probiotics and lifestyle modifications
In addition to screening, medical staff can provide patients with nutritional advice aimed at increasing the number of health-promoting microorganisms in the gut, including increased consumption of probiotics and prebiotics. These can be sourced from food and supplements, but are also positively impacted by certain lifestyle habits, sleep schedules, and exercise routine, as follows:
A healthy gut microbiome helps create a mucus layer that acts as a protective barrier alongside epithelial cells to prevent harmful bacteria from gaining entry via the intestinal walls. When health-promoting bacteria become imbalanced in the digestive tract, this process may not be put into motion, which could lead to an increased risk of the patient developing certain bowel disorders, such as inflammatory bowel disease or irritable bowel syndrome. Both of these conditions can develop due to a gut microbiome imbalance, an increased presence of harmful microorganisms, or through the use of antibiotic medication, resulting in harmful bacteria being able to penetrate the tissue, causing inflammation and a heightened risk of digestive system disorders developing.
Under normal conditions, when healthy bacteria in the intestines function properly, they may not cause any symptoms. However, if there is abdominal surgery, diabetes, scleroderma (a connective tissue disorder), or gastric or intestinal resection, this will result in changes to the bacterial balance in the gastrointestinal system. This causes pathogenic bacteria to grow and increase in number beyond normal levels (overgrowth of pathogenic bacteria), which may lead to malabsorption syndrome affecting the absorption of fats, carbohydrates, proteins, and vitamin B12
Under normal conditions, the gastrointestinal system contains bacteria called secondary bile acids synthesizing microbes, which help convert primary bile acids into secondary bile acids. These have the property of inhibiting the growth of Clostridium difficile, preventing it from secreting toxins that cause intestinal mucosal inflammation and diarrhea.
Taking antibiotics not only destroys harmful bacteria but also destroys secondary bile acids synthesizing microbes. Therefore, if Clostridium difficile enters the body and grows, it will secrete toxins that cause intestinal mucosal inflammation.
Factors related to this disease include genetics, immunity, and environment (diet). Under normal conditions, the body has beneficial bacteria such as Bacteroides and Firmicutes that have anti-inflammatory properties and produce a mucous layer that prevents pathogens from penetrating the gastrointestinal system. If genetics and immunity are abnormal, this will result in tissue inflammation, causing decreased bacterial diversity. Pathogenic bacteria secrete toxins, causing intestinal inflammation.
IBS has various types depending on the pathogenic bacteria causing it. Testing to identify the bacterial type can help provide more targeted treatment. Enterobacteriaceae is a pathogenic bacteria that causes gastrointestinal infections. Lactobacillus is a bacteria that produces acid from the fermentation of disaccharide sugars, which may cause abdominal pain and bloating. Bacteroides is a bacteria commonly found in IBS patients with diarrhea symptoms. Bifidobacterium and Faecalibacterium are beneficial bacteria that produce anti-inflammatory substances in the intestines.
Obesity is a condition with excessive fat accumulation in the body, especially in the abdominal area (visceral fat), which can trigger body-wide inflammation. Inflammatory conditions result in insulin resistance and increased risk of diabetes. Christensenellaceae bacteria help balance intestinal bacteria and prevent visceral fat accumulation, high blood lipids, metabolic syndrome, and diabetes.
Additionally, obese individuals have low levels of Akkermansia muciniphila bacteria, which is associated with weight loss. This "lean bacteria" stimulates mucus production to strengthen the intestinal wall and combat intestinal inflammation.
Bifidobacterium and Dehalobacterium bacteria stimulate the body to produce beneficial nutrients. However, if red meat (which is high in phosphatidylcholine) is consumed along with harmful bacteria such as Clostridiaceae and Neisseriaceae present in the intestines, they will convert Trimethylamine (TMA), which is absorbed into the bloodstream and metabolized by the liver, into Trimethylamine N-oxide (TMAO). This is a major cause of cardiovascular disease risk. Testing the balance of bacteria in the gastrointestinal system can help preliminarily diagnose cardiovascular disease risk from red meat consumption.
Research has found that patients with colon polyps have 415 times more Fusobacterium than normal individuals. This Fusobacterium inhibits the immune system that fights cancer by suppressing the function of NK cells (Natural Killer Cells), which are a type of white blood cell important to the body's natural immune system.
Gut microbiota help break down certain dietary fibers that the body cannot digest through fermentation of dietary fiber and production of metabolites called short-chain fatty acids (SCFAs). These stimulate the function of beta cells (a type of cell found in the pancreas that synthesizes and secretes insulin), resulting in reduced insulin resistance and reduced blood inflammation, as well as reduced leaky gut syndrome (a condition that causes body-wide inflammation). Bacteria with these properties include Bifidobacterium, Roseburia spp, and Faecalibacterium prausnitzii.
These include:
If you have at least 5 or more of the above symptoms, you may have a gut microbiome imbalance.
Microbiome screening uses next-generation sequencing (NGS) to identify bacterial DNA from stool samples, mapping hundreds of microbial species.
This test can assess:
The gut microbiome functions as a vital ecosystem interwoven with every organ system. Its diversity and stability determine not only digestive health but also metabolic, immune, and emotional resilience.
Maintaining microbial balance through nutrition, physical activity, and evidence-based interventions offers one of the most promising frontiers in preventive medicine.
Regular gut microbiome testing—conducted every six to twelve months after lifestyle modification—provides valuable insight into long-term wellness
Packages
articles